{"id":"placebo-to-ts-142","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"There is limited information available on the mechanism of action of TS-142.","oneSentence":"TS-142 is a drug with an unknown mechanism of action.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:29:08.169Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Phase 3 clinical trials for TS-142 are ongoing, but specific indications are not publicly available."}]},"trialDetails":[{"nctId":"NCT04746105","phase":"PHASE1","title":"A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea.","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Co., Ltd.","startDate":"2021-02-24","conditions":"Patients with Mild Obstructive Sleep Apnea Hypopnea","enrollment":46},{"nctId":"NCT04169893","phase":"PHASE1","title":"A Phase I Study of TS-142 in Healthy Participants (Single Doses)","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Co., Ltd.","startDate":"2015-10-17","conditions":"Healthy Volunteer","enrollment":32},{"nctId":"NCT04573725","phase":"PHASE2","title":"Early Phase 2 Clinical Study of TS-142 in Patients with Insomnia Disorder","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Co., Ltd.","startDate":"2017-07-07","conditions":"Insomnia Disorder","enrollment":24},{"nctId":"NCT04087707","phase":"PHASE2","title":"Safety, Pharmacokinetic, and Pharmacodynamic Study of TS-142 in Healthy Subjects","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Co., Ltd.","startDate":"2019-09-17","conditions":"Healthy Volunteer","enrollment":23},{"nctId":"NCT05819710","phase":"PHASE1","title":"A Study to Investigate the Next-day Residual Effects of TS-142 in Healthy Elderly Subjects","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Co., Ltd.","startDate":"2023-05-15","conditions":"Healthy Subjects","enrollment":43},{"nctId":"NCT04169906","phase":"PHASE1","title":"A Phase I Study of TS-142 in Healthy Participants (Repeated Doses)","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Co., Ltd.","startDate":"2016-07-06","conditions":"Healthy Volunteer","enrollment":24},{"nctId":"NCT04469023","phase":"PHASE2","title":"Late Phase II Study of TS-142 in Patients with Insomnia","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Co., Ltd.","startDate":"2020-09-09","conditions":"Patients with Insomnia","enrollment":179},{"nctId":"NCT04696952","phase":"PHASE1","title":"A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy Subjects","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Co., Ltd.","startDate":"2021-01-16","conditions":"Healthy Subjects","enrollment":61},{"nctId":"NCT04873323","phase":"PHASE1","title":"A QT/QTc Evaluation Study of TS-142 in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Co., Ltd.","startDate":"2021-06-07","conditions":"Healthy Subjects","enrollment":59},{"nctId":"NCT05453136","phase":"PHASE3","title":"Phase III Study of TS-142 in Patients with Insomnia","status":"COMPLETED","sponsor":"Taisho Pharmaceutical Co., Ltd.","startDate":"2022-08-30","conditions":"Patients with Insomnia","enrollment":1155},{"nctId":"NCT04464239","phase":"PHASE1","title":"A Single Ascending and Repeated Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TS-142 in Healthy Participants","status":"COMPLETED","sponsor":"Taisho Pharmaceutical R&D Inc.","startDate":"2020-09-14","conditions":"Healthy Volunteers","enrollment":28}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo to TS-142","genericName":"Placebo to TS-142","companyName":"Taisho Pharmaceutical Co., Ltd.","companyId":"taisho-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"TS-142 is a drug with an unknown mechanism of action. Used for Phase 3 clinical trials for TS-142 are ongoing, but specific indications are not publicly available..","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}